NCT06968546View on ClinicalTrials.gov

Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 31, 2028

Study Completion Date

March 31, 2028

Conditions
TraumatologyWounds and InjuryFractures BoneAnalgesiaPainPain ManagementAcute Pain
Interventions
DRUG

Intranasal Sufentanil

After randomization, the children will receive intranasal Sufentanil .

DRUG

Intranasal Ketamine (IN)

After randomization, chidren will receive intranasal Ketamine

Trial Locations (1)

06000

Hôpital lenval, Nice

All Listed Sponsors
lead

Fondation Lenval

OTHER